H1N1 TREATMENT US

Shahriar Koochekpour, MD, PhD, Assistant Professor of Microbiology and Immunology, Biochemistry and Molecular Biology, and Genetics at LSU Health Sciences Center New Orleans, led research that has discovered, for the first time, a genetic mutation in African-American men with a family history of prostate cancer who are at increased risk for the disease.

View original post here:
Genetic mutation in African-American men with family history of prostate cancer discovered (News-Medical-Net)

Data from two Phase III studies of Merck’s investigational fixed-dose combinations of mometasone furoate and formoterol fumarate (MF/F) were presented by researchers today in two poster presentations at the American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting.

See original here:
Merck’s MF/F Phase III study data presented at AAAAI annual meeting (News-Medical-Net)

Researchers at the La Jolla Institute for Allergy & Immunology have found that previous influenza infections may provide at least some level of immunity to the H1N1 “swine” flu. “The question we asked was, “Is the swine flu more like the seasonal flu or like a totally new strain of influenza where there would be no immunity?,” said Alessandro Sette, Ph.D., an internationally recognized vaccine …

View post:
Previous flu infections can reduce the severity of H1N1 (News-Medical-Net)

( La Jolla Institute for Allergy and Immunology ) Researchers at the La Jolla Institute for Allergy & Immunology have found that previous influenza infections may provide at least some level of immunity to the H1N1 “swine” flu.

Here is the original post:
La Jolla Institute finds previous seasonal flu infections may provide some level of H1N1 immunity (EurekAlert!)

NexBio, Inc. announced the presentation of new data at the 2009 annual American College of Allergy, Asthma, and Immunology in Miami, Florida. The presentation was entitled “DAS181 (Fludase®), a Sialidase, Decreases Airway Resistance and Has Potent Anti-inflammatory Effects in Animal Models of Asthma”.

The rest is here:
NexBio(R) Presents Data Showing Anti-Asthma Activity Of DAS181 (Fludase(R)) At ACAAI 2009 (Medical News Today)